Erdosteine Market Size By Application (Bronchitis, Chronic Obstructive Pulmonary Disease, Nasopharyngitis), By End-Use (Pharmaceutical, Contract Manufacturing Companies, Research Institute), Industry Analysis, Regional Outlook, Competitive Market Share & Forecast, 2016 – 2027

Published Date: May 2021  |  Report ID: GMI3371  |  Authors: Kunal Ahuja, Kritika Mamtani

Report Format: PDF   |   Pages: 130   |   Base Year: 2020




Report Content

Chapter 1   Methodology & Scope

1.1    Methodology

1.2    Market definitions

1.3    Market estimation & forecast parameters

1.4    Data Sources

1.4.1    Primary

1.4.2    Secondary

1.4.2.1    Paid Sources

1.4.2.2    Public Sources

Chapter 2   Executive Summary

2.1    Erdosteine (API) industry 3600 synopsis, 2021 - 2027

2.1.1    Business Trends

2.1.2    Regional trends

2.1.3    Application trends

2.1.4    End-use trends

Chapter 3   Erdosteine (API) Industry Insights

3.1    Industry segmentation

3.2    Impact of COVID-19 on the global economy

3.3    Industry ecosystem analysis

3.3.1    Vendor matrix

3.3.2    Distribution channel analysis

3.3.2.1    Distributors/ Suppliers

3.3.2.2    Contract Manufacturing

3.3.3    Impact of COVID-19 on industry value chain

3.4    Regulatory landscape

3.4.1    U.S.

3.4.2    Europe

3.4.3    Asia Pacific

3.4.3.1    Japan

3.4.3.2    Australia

3.4.3.3    India

3.5    Technology Landscape

3.5.1    Erdosteine synthesis

3.6    Cost structure analysis, 2020

3.6.1    Standard operating cost

3.6.2    Raw material cost

3.6.3    Labor cost

3.7    Component used in API manufacturing

3.8    Raw material analysis, Impact of COVID-19 on supply

3.8.1    Thioglycolic acid

3.8.2    Chloroacetyl chloride

3.8.3    Isopropyl Alcohol

3.8.4    HCL

3.8.5    Methylene Dichloride

3.9    Impact of COVID-19 on Pricing analysis

3.10    Industry impact forces

3.10.1    Growth drivers

3.10.1.1    North America: Growing trends towards cigarette smoking and exposure to tobacco smoke leading to increase in COPD

3.10.1.2    Europe: Exposure to polluted air quality leading to development of serious medical conditions like bronchitis

3.10.1.3    Asia Pacific: Pharmaceutical market expansion

3.10.2    Industry pitfalls & challenges

3.10.2.1    Limitation of the drug with certain medical condition

3.11    Growth potential analysis, 2020

3.11.1    Emerging business model

3.11.1.1    New product launch

3.11.1.2    Collaboration/ Partnership

3.11.1.3    Acquisition

3.12    Porter’s analysis

3.13    Competitive landscape, 2020

3.13.1    Company market share analysis, 2020

3.13.2    Strategy dashboard

3.13.3    Production capacity by company

3.13.4    Production capacity by region

3.13.5    Impact of COVID-19 on consumer buying behavior

3.14    PESTEL analysis

3.15    Other expectorant market overview

3.16    Overview of final product formulation for erdosteine

3.17    Innovation & sustainability

3.18    Patent landscape

3.19    Impact of COVID-19 on erdosteine demand by end-use

3.19.1    Pharmaceutical

3.19.2    CMOs

3.19.3    Research Institutes

Chapter 4   Erdosteine (API) Market, By Application

4.1    Key application trends

4.2    Bronchitis

4.2.1    Global erdosteine (API) market from bronchitis, 2016 - 2027, (Tons) (USD Million)

4.2.2    Global erdosteine (API) market from bronchitis, by region, 2016 - 2027, (Tons) (USD Million)

4.3    Chronic obstructive pulmonary disease (COPD)

4.3.1    Global erdosteine (API) market from COPD, 2016 - 2027, (Tons) (USD Million)

4.3.2    Global erdosteine (API) market from COPD, by region, 2016 - 2027, (Tons) (USD Million)

4.4    Nasopharyngitis

4.4.1    Global erdosteine (API) market from nasopharyngitis, 2016 - 2027, (Tons) (USD Million)

4.4.2    Global erdosteine (API) market from nasopharyngitis, by region, 2016 - 2027, (Tons) (USD Million)

4.5    Others

4.5.1    Global erdosteine (API) market from other application, 2016 - 2027, (Tons) (USD Million)

4.5.2    Global erdosteine (API) market from other application, by region, 2016 - 2027, (Tons) (USD Million)

Chapter 5   Erdosteine (API) Market, By End-Use

5.1    Key end-use trends

5.2    Pharmaceutical

5.2.1    Global erdosteine (API) market from pharmaceutical, 2016 - 2027, (Tons) (USD Million)

5.2.2    Global erdosteine (API) market from pharmaceutical, by region, 2016 - 2027, (Tons) (USD Million)

5.3    Contract manufacturing companies (CMO’s)

5.3.1    Global erdosteine (API) market from Contract manufacturing companies, 2016 - 2027, (Tons) (USD Million)

5.3.2    Global erdosteine (API) market from CMOs, by region, 2016 - 2027, (Tons) (USD Million)

5.4    Research Institute

5.4.1    Global erdosteine (API) market from research institute, 2016 - 2027, (Tons) (USD Million)

5.4.2    Global erdosteine (API) market from research institute, by region, 2016 - 2027, (Tons) (USD Million)

Chapter 6   Erdosteine (API) Market, By Region

6.1    Key regional trends

6.2    Latin America (LATAM)

6.2.1    LATAM erdosteine (API) market, 2016 - 2027, (Tons) (USD Million)

6.2.2    LATAM erdosteine (API) market, by application, 2016 - 2027, (Tons) (USD Million)

6.2.3    LATAM erdosteine (API) market, by end-use, 2016 - 2027, (Tons) (USD Million)

6.2.4    Brazil

6.2.4.1    Brazil erdosteine (API) market, 2016 - 2027, (Tons) (USD Million)

6.2.4.2    Brazil erdosteine (API) market, by application, 2016 - 2027, (Tons) (USD Million)

6.2.4.3    Brazil erdosteine (API) market, by end-use, 2016 - 2027, (Tons) (USD Million)

6.3    Middle East & Africa (MEA)

6.3.1    MEA erdosteine (API) market, 2016 - 2027, (Tons) (USD Million)

6.3.2    MEA erdosteine (API) market, by application, 2016 - 2027, (Tons) (USD Million)

6.3.3    MEA erdosteine (API) market, by end-use, 2016 - 2027, (Tons) (USD Million)

6.3.4    Saudi Arabia

6.3.4.1    Saudi Arabia erdosteine (API) market, 2016 - 2027, (Tons) (USD Million)

6.3.4.2    Saudi Arabia erdosteine (API) market, by application, 2016 - 2027, (Tons) (USD Million)

6.3.4.3    Saudi Arabia erdosteine (API) market, by end-use, 2016 - 2027, (Tons) (USD Million)

6.3.5    South Africa

6.3.5.1    South Africa erdosteine (API) market, 2016 - 2027, (Tons) (USD Million)

6.3.5.2    South Africa erdosteine (API) market, by application, 2016 - 2027, (Tons) (USD Million)

6.3.5.3    South Africa erdosteine (API) market, by end-use, 2016 - 2027, (Tons) (USD Million)

6.3.6    UAE

6.3.6.1    UAE erdosteine (API) market, 2016 - 2027, (Tons) (USD Million)

6.3.6.2    UAE erdosteine (API) market, by application, 2016 - 2027, (Tons) (USD Million)

6.3.6.3    UAE erdosteine (API) market, by end-use, 2016 - 2027, (Tons) (USD Million)

Chapter 7   Company Profiles

7.1    Recipharm AB

7.1.1    Business Overview

7.1.2    Financial Data

7.1.3    Product Landscape

7.1.4    SWOT Analysis

7.1.5    Strategic Outlook

7.2    Taj Pharmaceuticals Limited

7.2.1    Business Overview

7.2.2    Financial Data

7.2.3    Product Landscape

7.2.4    SWOT Analysis

7.3    Wuhan Hezhong Bio-Chemical Manufacture Co., Ltd.

7.3.1    Business Overview

7.3.2    Financial Data

7.3.3    Product Landscape

7.3.4    SWOT Analysis

7.4    Delta Finochem Pvt. Ltd.

7.4.1    Business Overview

7.4.2    Financial Data

7.4.3    Product Landscape

7.4.4    SWOT Analysis

7.5    Alitair Pharmaceuticals, Inc.

7.5.1    Business Overview

7.5.2    Financial Data

7.5.3    Product Landscape

7.5.4    SWOT Analysis

7.6    Salvavidas Pharmaceutical Private Limited

7.6.1    Business Overview

7.6.2    Financial Data

7.6.3    Product Landscape

7.6.4    SWOT Analysis

7.7    Zhejiang Kangle Pharmaceutical Co., Ltd.

7.7.1    Business Overview

7.7.2    Financial Data

7.7.3    Product Landscape

7.7.4    SWOT Analysis

7.8    Wuhan Yuancheng Pharmaceutical

7.8.1    Business Overview

7.8.2    Financial Data

7.8.3    Product Landscape

7.8.4    SWOT Analysis

7.9    Hanmi Pharmaceuticals Co., Ltd.

7.9.1    Business Overview

7.9.2    Financial Data

7.9.3    Product Landscape

7.9.4    SWOT Analysis

7.10    Shandong Luoxin Pharmaceutical

7.10.1    Business Overview

7.10.2    Financial Data

7.10.3    Product Landscape

7.10.4    SWOT Analysis

7.11    Asmoh Laboratories Ltd.

7.11.1    Business Overview

7.11.2    Financial Data

7.11.3    Product Landscape

7.11.4    SWOT Analysis

7.12    Hikma Pharmaceuticals

7.12.1    Business Overview

7.12.2    Financial Data

7.12.3    Product Landscape

7.12.4    SWOT Analysis

7.13    Jigs Chemical

7.13.1    Business Overview

7.13.2    Financial Data

7.13.3    Product Landscape

7.13.4    SWOT Analysis
 

Data Tables

TABLE 1    Erdosteine (API) industry 3600 synopsis, 2021 - 2027

TABLE 2    Global erdosteine (API) market, 2016 - 2027, (Tons) (USD Million)

TABLE 3    Global erdosteine (API) market volume, by region, 2013-2024 (Tons)

TABLE 4    Global erdosteine (API) market revenue, by region, 2013-2024 (USD Million)

TABLE 5    Global erdosteine (API) market volume, by application, 2016 - 2027, (Tons)

TABLE 6    Global erdosteine (API) market revenue, by application, 2016 - 2027, (USD Million)

TABLE 7    Global erdosteine (API) market volume, by end-use, 2016 - 2027 (Tons)

TABLE 8    Global erdosteine (API) market revenue, by end-use, 2016 - 2027 (USD Million)

TABLE 9    Vendor matrix

TABLE 10    Erdosteine (API) distribution channel analysis

TABLE 11    Operating cost distribution

TABLE 12    Industry impact forces

TABLE 13    Global erdosteine (API) market from bronchitis, 2016 - 2027, (Tons) (USD Million)

TABLE 14    Global erdosteine (API) market volume from bronchitis, by region, 2016 - 2027, (Tons)

TABLE 15    Global erdosteine (API) market revenue from bronchitis, by region, 2016 - 2027, (USD Million)

TABLE 16    Global erdosteine (API) market from COPD, 2016 - 2027, (Tons) (USD Million)

TABLE 17    Global erdosteine (API) market volume from COPD, by region, 2016 - 2027, (Tons)

TABLE 18    Global erdosteine (API) market revenue from COPD, by region, 2016 - 2027, (USD Million)

TABLE 19    Global erdosteine (API) market from nasopharyngitis, 2016 - 2027, (Tons) (USD Million)

TABLE 20    Global erdosteine (API) market volume from nasopharyngitis, by region, 2016 - 2027, (Tons)

TABLE 21    Global erdosteine (API) market revenue from nasopharyngitis, by region, 2016 - 2027, (USD Million)

TABLE 22    Global erdosteine (API) market from other application, 2016 - 2027, (Tons) (USD Million)

TABLE 23    Global erdosteine (API) market volume from other application, by region, 2016 - 2027, (Tons)

TABLE 24    Global erdosteine (API) market revenue from other application, by region, 2016 - 2027, (USD Million)

TABLE 25    Global erdosteine (API) market from pharmaceutical, 2016 - 2027, (Tons) (USD Million)

TABLE 26    Global erdosteine (API) market volume from pharmaceutical, by region, 2016 - 2027, (Tons)

TABLE 27    Global erdosteine (API) market revenue from pharmaceutical, by region, 2016 - 2027, (USD Million)

TABLE 28    Global erdosteine (API) market from CMOs, 2016 - 2027, (Tons) (USD Million)

TABLE 29    Global erdosteine (API) market volume from CMOs, by region, 2016 - 2027, (Tons)

TABLE 30    Global erdosteine (API) market revenue from CMOs, by region, 2016 - 2027, (USD Million)

TABLE 31    Global erdosteine (API) market from research institute, 2016 - 2027, (Tons) (USD Million)

TABLE 32    Global erdosteine (API) market volume from research institute, by region, 2016 - 2027, (Tons)

TABLE 33    Global erdosteine (API) market revenue from research institute, by region, 2016 - 2027, (USD Million)

TABLE 34    LATAM erdosteine (API) market, 2016 - 2027, (Tons) (USD Million)

TABLE 35    LATAM erdosteine (API) market volume, by application, 2016 - 2027, (Tons)

TABLE 36    LATAM erdosteine (API) market revenue, by application, 2016 - 2027, (USD Million)

TABLE 37    LATAM erdosteine (API) market volume, by end-use, 2016 - 2027, (Tons)

TABLE 38    LATAM erdosteine (API) market revenue, by end-use, 2016 - 2027, (USD Million)

TABLE 39    Brazil erdosteine (API) market, 2016 - 2027, (Tons) (USD Million)

TABLE 40    Brazil erdosteine (API) market volume, by application, 2016 - 2027, (Tons)

TABLE 41    Brazil erdosteine (API) market revenue, by application, 2016 - 2027, (USD Million)

TABLE 42    Brazil erdosteine (API) market volume, by end-use, 2016 - 2027, (Tons)

TABLE 43    Brazil erdosteine (API) market revenue, by end-use, 2016 - 2027, (USD Million)

TABLE 44    MEA erdosteine (API) market, 2016 - 2027, (Tons) (USD Million)

TABLE 45    MEA erdosteine (API) market volume, by application, 2016 - 2027, (Tons)

TABLE 46    MEA erdosteine (API) market revenue, by application, 2016 - 2027, (USD Million)

TABLE 47    MEA erdosteine (API) market volume, by end-use, 2016 - 2027, (Tons)

TABLE 48    MEA erdosteine (API) market revenue, by end-use, 2016 - 2027, (USD Million)

TABLE 49    Saudi Arabia erdosteine (API) market, 2016 - 2027, (Tons) (USD Million)

TABLE 50    Saudi Arabia erdosteine (API) market volume, by application, 2016 - 2027, (Tons)

TABLE 51    Saudi Arabia erdosteine (API) market revenue, by application, 2016 - 2027, (USD Million)

TABLE 52    Saudi Arabia erdosteine (API) market volume, by end-use, 2016 - 2027, (Tons)

TABLE 53    Saudi Arabia erdosteine (API) market revenue, by end-use, 2016 - 2027, (USD Million)

TABLE 54    South Africa erdosteine (API) market, 2016 - 2027, (Tons) (USD Million)

TABLE 55    South Africa erdosteine (API) market volume, by application, 2016 - 2027, (Tons)

TABLE 56    South Africa erdosteine (API) market revenue, by application, 2016 - 2027, (USD Million)

TABLE 57    South Africa erdosteine (API) market volume, by end-use, 2016 - 2027, (Tons)

TABLE 58    South Africa erdosteine (API) market revenue, by end-use, 2016 - 2027, (USD Million)

TABLE 59    UAE erdosteine (API) market, 2016 - 2027, (Tons) (USD Million)

TABLE 60    UAE erdosteine (API) market volume, by application, 2016 - 2027, (Tons)

TABLE 61    UAE erdosteine (API) market revenue, by application, 2016 - 2027, (USD Million)

TABLE 62    UAE erdosteine (API) market volume, by end-use, 2016 - 2027, (Tons)

TABLE 63    UAE erdosteine (API) market revenue, by end-use, 2016 - 2027, (USD Million)
 

Charts & Figures

FIG. 1    Air pollution sources, 2017, (% share)

FIG. 2    Lung disease contributing to estimated current annual deaths, 2018, (% share)

FIG. 3    Chronic Obstructive pulmonary disease 35 years and over, 2017, (% share)

FIG. 4    Chronic Obstructive pulmonary disease 35 years and over, 2017, ()

FIG. 5    Industry segmentation

FIG. 6    Industry ecosystem analysis

FIG. 7    Value chain of generic pharmaceuticals

FIG. 8    Erdosteine synthesis

FIG. 9    New Microfluidic Technique & Continuous Process Method

FIG. 10    Cost structure of API manufacturing, 2020, (% share)

FIG. 11    Raw material break-up for erdosteine, 2020, (% share)

FIG. 12    Reactor Types

FIG. 13    Thioglycolic acid market estimates & forecast, 2016 - 2027, (Kilo Ton)

FIG. 14    Chloroacetyl chloride market estimates & forecast, 2016 - 2027, (USD Million)

FIG. 15    Isopropyl alcohol market estimates & forecast, 2016 - 2027, (USD Million)

FIG. 16    Hydrochloric acid market estimates & forecast, 2016 - 2027, (USD Billion)

FIG. 17    Methylene dichloride market estimates & forecast, 2016 - 2027, (USD Million)

FIG. 18    Erdosteine (API) ex-factory price, 2016-2027, (USD/kilo)

FIG. 19    North America current cigarette smoking data, by age group, 2017, (% share)

FIG. 20    Tobacco products among high school students, by type, 2018, (% share)

FIG. 21    Asia Pacific pharmaceutical market, 2013-2024, (USD Billion)

FIG. 22    India primary cause of respiratory diseases, (% share), 2017

FIG. 23    Growth potential analysis, 2020

FIG. 24    Porter’s analysis

FIG. 25    Erdosteine (API) company market share analysis, 2020

FIG. 26    Porter’s analysis

FIG. 27    SWOT Analysis, Recipharm AB

FIG. 28    SWOT Analysis, Taj Pharmaceuticals

FIG. 29    SWOT Analysis, Wuhan Hezhong Bio-Chemical Manufacture Co., Ltd

FIG. 30    SWOT Analysis, Delta Finochem Pvt. Ltd

FIG. 31    SWOT Analysis, Alitair Pharmaceuticals Inc.

FIG. 32    SWOT Analysis, Salvavidas Pharmaceutical Private Limited

FIG. 33    SWOT Analysis, Zhejiang Kangle Pharmaceuticals Co., Ltd.

FIG. 34    SWOT Analysis, Wuhan Yuancheng Pharmaceutical

FIG. 35    SWOT Analysis, Hanmi Pharmaceuticals Co., Ltd.

FIG. 36    SWOT Analysis, Shandong Luoxin Pharmaceutical

FIG. 37    SWOT Analysis, Asmoh Laboratories Ltd

FIG. 38    SWOT Analysis, Hikma Pharmaceuticals

FIG. 39    SWOT Analysis, Jigs Chemicals
  

Premium Report Details

  • Published Date: May 2021
  • Pages: 130
  • Tables: 148
  • Charts / Figures: 40
  • Companies covered: 13
  • Countries covered: 5

Get a report that explains COVID-19 impact on this market

Buy Now

Need a Discount? Get in touch with us for special pricing

Request Discount

 Connect with our sales team

Chat with us
We use cookies to enhance user experience. (Privacy Policy) X